Seminars in Hematology

Papers
(The H4-Index of Seminars in Hematology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Special issue on chronic lymphocytic leukemia: Prognostication and therapeutic options introductory editorial140
CAR T-cell therapy comes of age: Introductory editorial for the special issue60
Clinical applications of circulating tumor DNA in Hodgkin lymphoma40
Extramedullary myeloma in the era of CAR T-cell and bispecific antibody therapies33
Insights from the 12th International Workshop on Waldenstrom's Macroglobulinemia31
Evolving Insights into Mitochondrial Presence in RBC in Sickle Cell Disease: Red Blood Cell and Reticulocyte Pathophysiology, Therapeutic Strategies, and Future Directions29
Clonality in immune aplastic anemia: Mechanisms of immune escape or malignant transformation28
Updates on current and future research in acute myeloid leukemia27
The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-1922
How to set up a clinical research center in Brazil, as an example of a middle-income country21
Epidemiology and etiology of diffuse large B-cell lymphoma20
Lessons learned from the Eµ-TCL1 mouse model of CLL19
Somatic mutations in “benign” blood diseases19
Immune-driven clonal cell selection at the intersection among cancer, infections, autoimmunity and senescence18
The future of lymphoma diagnosis, prognosis, and treatment monitoring in countries with limited access to pathology services17
Antibody and immunotherapy in diffuse large B-cell lymphoma17
More disease-modifying therapies for sickle cell disease: Are small molecules and drug repurposing the way forward?16
TET2 mutation as prototypic clonal hematopoiesis lesion16
0.083492994308472